儿童心脏移植患者腺苷负荷灌注心脏磁共振的可行性与安全性
有血管病与无血管病患者的心肌灌注储备无显著差异(中位数1.43 vs 1.48,P=0.49)。该方法安全可行,但需更大样本研究。
要点
- 腺苷负荷灌注心脏MRI在儿童心脏移植患者中安全可行,无心脏传导阻滞等并发症。
- 心肌灌注储备在有和无冠状动脉移植物血管病患者间无显著差异(P=0.49)。
- 观察者内和观察者间重复性分别为97%和92%。
诊断标准与关键数值
- 心肌灌注储备中位数:有血管病患者1.43,无血管病患者1.48,P=0.49。
- 移植后6年内患者心肌灌注储备中位数1.57,移植后6年以上患者1.47,P=0.46。
- 观察者内重复性97%,观察者间重复性92%。
临床应用与阅片要点
- 腺苷负荷灌注心脏磁共振可用于儿童心脏移植患者微血管病变评估,但结果需谨慎解读。
- 有和无冠状动脉移植物血管病患者心肌灌注储备无显著差异,不能单独用于诊断血管病。
- 检查中未发生心脏传导阻滞等并发症,但需注意腺苷使用的安全性监测。
局限性
- 原文指出需要更大样本研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Pediatric heart transplant patients require cardiac catheterization to monitor for coronary allograft vasculopathy. Cardiac catheterization has no safe and consistent method for measuring microvascular disease. Stress perfusion cardiac magnetic resonance imaging (MRI) assessing microvascular disease has been performed in adults.
OBJECTIVE: To investigate the feasibility and safety of performing cardiac MRI with quantitative adenosine stress perfusion testing in pediatric heart transplant patients with and without coronary allograft vasculopathy.
MATERIALS AND METHODS: All pediatric heart transplant patients with coronary vasculopathy at our institution were asked to participate. Age- and gender-matched pediatric heart transplant patients without vasculopathy were recruited for comparison. Patients underwent cardiac MRI with adenosine stress perfusion testing.
RESULTS: Sixteen pediatric heart transplant patients, ages 6-22 years, underwent testing. Nine patients had vasculopathy by angiography. No heart block or other complications occurred during the study. The myocardial perfusion reserve for patients with vasculopathy showed no significant difference with comparison patients (median: 1.43 vs. 1.48; P=0.49). Values for both groups were lower than expected values based on previous adult studies. The patients were also analyzed for time after transplant and the number of rejection episodes. Patients within 6 years of transplantation had a nonsignificant trend toward a higher myocardial perfusion reserve (median: 1.57) versus patients with older transplants (median: 1.47; P=0.46). Intra- and interobserver reproducibility were 97% and 92%, respectively.
CONCLUSION: Myocardial perfusion reserve is a safe and feasible method for estimating myocardial perfusion in pediatric heart transplant patients. There is no reliable way to monitor microvascular disease in pediatric patients. This method shows potential and deserves investigation in a larger cohort.
引用
- Duran SR, Huffaker T, Dixon B, et al. Feasibility and safety of quantitative adenosine stress perfusion cardiac magnetic resonance imaging in pediatric heart transplant patients with and without coronary allograft vasculopathy. Pediatr Radiol. 2021. PMID: 33791838. doi:10.1007/s00247-021-04977-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。